Bristol-Myers Squibb Co.

The global pharmaceutical company has received U.S. Food and Drug Administration approval for commercial cell therapy manufacturing in Devens.

Five life science companies with significant operations in Central Mass. were among the 43 firms across Massachusetts chosen to split $24.4 million in tax incentive awards.

Central Massachusetts manufacturers must rise to meet demand and the challenges of the current crisis, using innovation and partners, according to a slate of experts at Worcester Business Journal's Central Mass Manufacturing Summit & Awards event Thursday at the College of the Holy Cross in Worcester.

The Power 50 may not necessarily hold the most power in the region, but they are the people who most effectively wielded their power to have an outsized influence on the economy and the community within the last year.

Now, in its seventh year, the Manufacturing Excellence Awards seeks to accentuate the top performers in a highly complex and varied industry.

Eight women from around Central Massachusetts have earned the honor this year.

People are on the move at Adcare Hospital, ERA Key Spencer, Savers Bank, and more.

New York City pharmaceutical giant Bristol Myers Squibb has selected the head of Sanofi Pasteur's biologics manufacturing to be the new general manager of its expanding facility in Devens.

Arranta Bio, a microbiome contract development and manufacturing organization, is planning a $150-million facility in Boxborough to drastically increase its capacity beyond its sites in Watertown and Florida.

A 244,000-square-foot expansion at Bristol Myers Squibb's Devens facility will add to the drugmaker's efforts to fight cancer using specialized technology, company officials said during a virtual tour Tuesday.